VIMTALABS Intraday Analysis...

VIMTALABS Share Price

Open 131.00 Change Price %
High 131.00 1 Day -1.85 -1.41
Low 127.55 1 Week -1.40 -1.07
Close 129.55 1 Month -0.55 -0.42
Volume 69077 1 Year 25.10 24.03
52 Week High 164.30
52 Week Low 88.40
VIMTALABS Important Levels
Resistance 2 132.75
Resistance 1 131.43
Pivot 129.37
Support 1 127.67
Support 2 126.35
NSE INDIA Most Active Stocks
JPASSOCIAT 17.05 -6.06%
INFIBEAM 119.85 -16.42%
SUZLON 16.10 -1.23%
RCOM 19.90 0.25%
UNITECH 6.65 -4.32%
IBREALEST 201.50 -7.59%
GMRINFRA 16.45 -1.79%
SOUTHBANK 28.60 -2.39%
HFCL 27.95 -4.93%
CAPACITE 342.55 37.02%
More..
NSE INDIA Top Gainers Stocks
CAPACITE 342.55 37.02%
NAGREEKEXP 35.15 19.97%
SHOPERSTOP 500.40 19.68%
LCCINFOTEC 0.35 16.67%
VISASTEEL 19.90 15.70%
TVTODAY 414.45 15.37%
GUFICBIO 83.25 11.90%
SCI 97.95 11.88%
SCI 97.95 11.88%
SCI 97.95 11.88%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.10 -33.33%
TIFIN 589.55 -25.67%
ADHUNIKIND 63.30 -19.97%
PRAKASHSTL 0.25 -16.67%
INFIBEAM 119.85 -16.42%
VICEROY 19.40 -11.82%
PREMIERPOL 32.35 -11.37%
DAMODARIND 100.25 -10.01%
TINPLATE 224.65 -9.76%
VASWANI 16.90 -9.63%
More..

Vimta Labs Limited (NSE: VIMTALABS)

VIMTALABS Technical Analysis 2
As on 25th Sep 2017 VIMTALABS Share Price closed @ 129.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 118.86 & Strong Sell for SHORT-TERM with Stoploss of 138.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIMTALABS Target for September
1st Target up-side 144.33
2nd Target up-side 154.34
3rd Target up-side 164.35
1st Target down-side 115.77
2nd Target down-side 105.76
3rd Target down-side 95.75
VIMTALABS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 44.36 Sideways
MFI (14) MFI is 71.39 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 144.50
10 Day Avg Volume Traded -41.91 % Less then 10 Day Average Volume
VIMTALABS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.vimta.com
VIMTALABS Address
VIMTALABS
Plot Nos.: 142/2 and 142
IDA Phase II
Hyderabad, 500051
India
Phone: 91 40 2726 4141
Fax: 91 40 2726 3657
VIMTALABS Latest News
Clarification sought from Vimta Labs Ltd   Hindu Business Line   - 18th Mar 15
Vimta Labs surges 20% on heavy volumes   Business Standard   - 13th Mar 15
Vimta Labs Ltd gets favorable verdict on service tax disputes   Equity Bulls   - 23rd Oct 14
CRISIL ratings for Indian debt instruments-Aug 12   Reuters   - 12th Aug 14
Buy Vimta Labs, Wockhardt, Allahabad Bank: Manav Chopra   Moneycontrol.com   - 07th Jul 14
Vimta Labs fails to execute Rs 30 cr projects   Business Standard   - 19th Sep 12
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading ...   Hindu Business Line   - 09th Apr 12
Vimta Labs standalone Dec '14 sales at Rs 25.15 crore   Moneycontrol.com   - 29th Mar 12
European firm seen circling Vimta Labs   Daily News & Analysis   - 04th Jun 11
Vimta Labs Board to consider Dividend for 2009-10   Equity Bulls   - 25th Apr 10
Interactive Technical Analysis Chart Vimta Labs Limited ( VIMTALABS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vimta Labs Limited
VIMTALABS Business Profile
Vimta Labs Limited provides contract research and testing services primarily in India. It offers analytical testing services for food and agriculture products, and drugs and pharmaceuticals, as well as tests water samples for various purposes and specifications. The company also provides environmental assessment services, including site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; occupational health and safety, industrial hygiene; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; industrial emission source monitoring; offshore sampling and analysis of marine water and sediments; marine ecological studies; marine impact assessment; rehabilitation and resettlement studies; forestry and ecological studies; geo-technical studies; geological and hydro-geological studies; land use/ land cover studies based on remote sensing; socio-economic studies; due diligence studies; epidemiological studies; wasteland management studies; and study on bio-indicators, as well as offers various other services under environment chemistry. In addition, it provides clinical research services, including Phase-I/ bioequivalence studies, as well as screening and recruitment services; and conducts studies on arious dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, transdermal patches, injectibles, etc. Further, the company offers clinical reference lab services; pre-clinical services, including drug discovery services to pharmaceutical and biotech companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and services in the area of cell and molecular biology. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India.